Related Experiment Video
Updated: Aug 11, 2026
13:15
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
Published on: February 25, 2016
Mitochondrial-targeted drug and DNA delivery
1Northeastern University, Bouve College of Health Sciences, School of Pharmacy, Department of Pharmaceutical Sciences, 360 Huntington Avenue, Mugar 211, Boston, MA 02115, USA. v.weissig@neu.edu
Critical Reviews in Therapeutic Drug Carrier Systems
|August 13, 2003
Summary
Mitochondrial dysfunction is linked to numerous diseases, spurring the development of mitochondrial medicine. This field focuses on targeting mitochondria for therapeutic interventions, offering new treatment strategies for various human disorders.
Area of Science:
- Biomedical Research
- Cell Biology
- Mitochondrial Biology
Background:
- Mitochondrial research has surged since the late 1980s due to key discoveries.
- Mitochondrial dysfunction is implicated in diverse diseases including neurodegenerative disorders, obesity, diabetes, ischemia-reperfusion injury, and cancer.
- Mitochondria play critical roles in cellular energy production and apoptosis.
Purpose of the Study:
- To provide a comprehensive overview of current mitochondrial targeting strategies.
- To explore the therapeutic applications of targeting mitochondria in living cells.
- To highlight the emergence of mitochondrial medicine as a new biomedical field.
Main Methods:
- Review of recent scientific literature on mitochondrial targeting.
- Analysis of pharmacological and pharmaceutical efforts in mitochondrial research.
- Synthesis of information on strategies for manipulating mitochondrial functions.
Main Results:
- Mitochondrial targeting enables manipulation of mitochondrial functions for therapeutic benefit.
- Targeting strategies aim for selective cell protection, repair, or eradication.
- Emerging mitochondrial medicine offers novel therapeutic avenues.
Conclusions:
- Mitochondrial targeting is a promising approach in biomedical research.
- Targeting mitochondria can lead to innovative treatments for a range of diseases.
- Further development in this field holds significant therapeutic potential.
Related Concept Videos
02:59Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
01:46Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
01:39Mitochondrial Protein Sorting
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
01:19Translocation of Proteins into the Mitochondria
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.